rolipram has been researched along with Colorectal Neoplasms in 1 studies
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsunoda, T | 1 |
| Ota, T | 1 |
| Fujimoto, T | 1 |
| Doi, K | 1 |
| Tanaka, Y | 1 |
| Yoshida, Y | 1 |
| Ogawa, M | 1 |
| Matsuzaki, H | 1 |
| Hamabashiri, M | 1 |
| Tyson, DR | 1 |
| Kuroki, M | 1 |
| Miyamoto, S | 1 |
| Shirasawa, S | 1 |
1 other study available for rolipram and Colorectal Neoplasms
| Article | Year |
|---|---|
Inhibition of phosphodiesterase-4 (PDE4) activity triggers luminal apoptosis and AKT dephosphorylation in a 3-D colonic-crypt model.
Topics: Apoptosis; Cell Line, Tumor; Cluster Analysis; Colorectal Neoplasms; Cyclic Nucleotide Phosphodieste | 2012 |